[Inotropic action of cardiac glycosides in light of current conceptions of electromechanical coupling in the myocardium].
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001001:Anura; D002118:Calcium / Q000008:administration & dosage / Q000378:metabolism; D002301:Cardiac Glycosides / Q000008:administration & dosage / Q000494:pharmacology*; D002395:Catecholamines / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003285:Contractile Proteins / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011690:Purkinje Fibers / Q000187:drug effects; D011817:Rabbits; D012519:Sarcoplasmic Reticulum / Q000187:drug effects; D012964:Sodium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors
D002301:Cardiac Glycosides; D002395:Catecholamines; D003285:Contractile Proteins; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; D011188:Potassium; D002118:Calcium
Inotropnoe deĭstvie serdechnykh glikozidov v svete sovremennoĭ kontseptsii élektromekhanicheskogo sopriazheniia v miokarde.